{
  "8362719_syn_1": "Dx: SCLC.\nProcedure: EBUS-TBNA.\nNodes: 7 (42mm), 4R (31mm), 4L, 10R sampled.\nROSE: Malignant (SCLC).\nOutcome: Stable.",
  "8362719_syn_2": "INDICATIONS: Staging of suspected small cell lung cancer.\nPROCEDURE: EBUS-TBNA. A comprehensive mediastinal survey id[REDACTED] pathologically enlarged lymph nodes at stations 7, 4R, and 4L. Transbronchial needle aspiration confirmed small cell carcinoma via ROSE.\nCONCLUSION: Advanced stage disease.",
  "8362719_syn_3": "CPT 31653 (EBUS 3+ stations).\nStations: 7, 4R, 4L, 10R sampled.\nPathology: Positive for malignancy.\nNotes: 22G needle used. No complications.",
  "8362719_syn_4": "Resident Note\nCase: EBUS Staging\nPt: 72M\nFindings: Huge subcarinal node (42mm). Sampled 7, 4R, 4L, 10R.\nPath: SCLC confirmed on site.\nPlan: Oncology.",
  "8362719_syn_5": "ebus for mr [REDACTED]. big nodes. station 7 is massive. sampled 7 4r 4l 10r. positive for small cell. no bleeding. done.",
  "8362719_syn_6": "EBUS BRONCHOSCOPY Indication Small cell lung cancer staging enlarged mediastinal lymph nodes on imaging Pre op diagnosis Small cell lung cancer clinical stage Post op diagnosis Pending final pathology Anesthesia General anesthesia provided by anesthesia team Dr Martinez Equipment Pentax EB 1970UK linear EBUS scope Procedure narrative After successful intubation and adequate depth of anesthesia timeout performed EBUS bronchoscope inserted via ETT Initial inspection showed normal trachea sharp carina Systematic ultrasound examination Lymph node stations evaluated 2R 11mm normal echogenicity 4R 31mm ENLARGED loss of normal architecture 4L 24mm ENLARGED hypoechoic 7 42mm MARKEDLY ENLARGED heterogeneous 10R 18mm prominent 10L 16mm prominent 11R 21mm abnormal appearance TBNA sampling Station 7 42mm Needle 22G Pass 1 0758 visible tissue core Pass 2 0801 additional sample Pass 3 0803 for molecular studies Pass 4 0805 microbiology ROSE Result MALIGNANT small cell morphology id[REDACTED] Station 4R 31mm 3 passes performed ROSE Small cell carcinoma confirmed Station 4L 24mm 3 passes performed ROSE Malignant cells present Station 10R 18mm 2 passes performed ROSE Atypical cells Procedure completed 0822",
  "8362719_syn_7": "[Indication]\nSCLC Staging.\n[Anesthesia]\nGA.\n[Description]\nEBUS performed. Sampled 7, 4R, 4L, 10R. All enlarged. ROSE positive for SCLC.\n[Plan]\nRefer to Onco.",
  "8362719_syn_8": "We carried out the EBUS staging for [REDACTED]. The ultrasound revealed significantly enlarged nodes in the subcarinal and paratracheal regions. We took samples from stations 7, 4R, 4L, and 10R. The onsite pathologist confirmed small cell carcinoma. The patient tolerated the procedure well.",
  "8362719_syn_9": "Lymph node stations evaluated: 2R, 4R, 4L, 7, 10R, 10L, 11R.\nTBNA sampling:\nStation 7 (42mm): ROSE Result: MALIGNANT, small cell morphology id[REDACTED].\nStation 4R (31mm): ROSE: Small cell carcinoma confirmed.\nStation 4L (24mm): ROSE: Malignant cells present.\nStation 10R (18mm): ROSE: Atypical cells.",
  "8362719": "Patient: [REDACTED] | ID: [REDACTED] | Age: 72 | M Service Date: [REDACTED] | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: → 2R: 11mm, normal echogenicity → 4R: 31mm, ENLARGED, loss of normal architecture → 4L: 24mm, ENLARGED, hypoechoic\n→ 7: 42mm, MARKEDLY ENLARGED, heterogeneous → 10R: 18mm, prominent → 10L: 16mm, prominent → 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology id[REDACTED]\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient [REDACTED]-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: [REDACTED] 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN [REDACTED] | DOB [REDACTED] Date of Procedure: [REDACTED]\nProvider: Elliott, Mark DO | Interventional Pulmonology\nINDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings\nINFORMED CONSENT: Obtained, documented in chart\nPROCEDURE: EBUS-TBNA with ROSE\nANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel\nEQUIPMENT: Olympus EBUS bronchoscope\nTECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings:\nStation 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum\nStation 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance\nSAMPLING DETAILS:\nStation 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry\nPass 4: Cell block preparation\nStation 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells\nStation 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population\nStation 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation\nElastography used on Station 7 showing firm consistency (blue pattern)\nAirways: Bilaterally patent, no endobronchial lesions\nCOMPLICATIONS: None\nSPECIMENS: ✓ Cytology from all sampled stations ✓ Flow cytometry - Stations 7, 4R, 4L, 11R ✓ Cell blocks prepared ✓ Cultures sent (Station 7)\nTOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout\nPRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage.\nPLAN:\n6.\tHematology-Oncology urgent consultation\n7.\tFinal pathology with flow cytometry results in 3-5 days\n8.\tStaging CT chest/abdomen/pelvis\n9.\tBone marrow biopsy may be indicated\n10.\tF/U IP clinic 1 week\nMark Elliott, DO Interventional Pulmonology Signed: [REDACTED] 15:41\n________________________________________"
}
